Medicover AB

SE

Investment brief

Investment brief: Medicover AB

Create a free account to read 3 full briefs a month: verdict, strengths, risks, how you could invest and what the price implies. No card needed.

Founding members

The first 100 accounts get 3 months free

98 of 100 free places left · 2 taken

Create your account and get full access for 3 months — no card, no automatic charge. After that it is 20 € a month, only if you choose to continue.

Create a free account

Already have an account? Sign in

Recent signals

Medicover AB

Annual report published (ESEF)

Published by the issuer on 2026-03-30; collected by filings.xbrl.org on 2026-10-26 (210 days later). Figures enter askFlo's European rankings at the next batch.

Business performanceImportance: StandardReport filed

Recent events →

Key figures · FY2022

Revenue
€1.51bn
Growth
+9.6%
3-year growth (yearly)
—
Net income
€12.1m
Gross margin
22.2%
Operating margin
3.7%
Net margin
0.8%
Free cash flow
€29.6m
Cash
€40.4m
Long-term debt
€473.4m
Net cash
-€433m
Dividends + buybacks
€17.8m

Four-year trend

Revenue
2021: €1.38bn€1.38bn20212022: €1.51bn€1.51bn2022
Operating margin
2021: 11.6%11.6%20212022: 3.7%3.7%2022
Net income
2021: €101.8m€101.8m20212022: €12.1m€12.1m2022
Operating cash flow
2021: €216.7m€216.7m20212022: €170.2m€170.2m2022

Annual figures from the company's ESEF annual report; the earlier year is that report's comparative. Operating margin is computed in code as operating income divided by revenue.

Place in every ranking

ListsValuePlace
Fastest growing+9.6%#665 of 2,243
Most profitable3.7%#1308 of 1,765
Improving margins-7.9 pp#1493 of 1,553
Cash machines2%#1330 of 1,634
Strongest balance sheets-28.7%#738 of 1,274
Returning cash to shareholders1.2%#1336 of 1,699
Highest net margin0.8%#1530 of 1,995

Figures for FY2022 (period ending 2023-01-01) from the company's ESEF annual report (IFRS, consolidated), in EUR. Prior year comes from the same report's comparatives. A dash (—) means the figure was not tagged in a comparable form. These lists rank companies by reported figures. A high rank is a fact about the numbers, not a recommendation to buy, sell or hold, and not personalised advice. Past results do not predict future returns.

Find a company